Who owns the NEXLETOL trademark?

The NEXLETOL trademark is owned by Esperion Therapeutics, Inc..

What class is the NEXLETOL trademark registered in?

The NEXLETOL trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for NEXLETOL?

The USPTO serial number for NEXLETOL is 87847415.

What is the registration number for NEXLETOL?

NEXLETOL is registered under USPTO registration number 6064746.

Sealvo

Home Search: NEXLETOLNEXLETOL #87847415

Back

Updated Oct 14, 2026·27 searches this week

View on USPTO TSDR Find similar marks

NEX

USPTO Trademark Record

REGISTERED

NEXLETOL

SN 87847415·Reg 6064746·Filed Mar 23, 2018

Owner Esperion Therapeutics, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

NEXLETOL (Serial No. 87847415), Registration No. 6064746, is a registered US trademark filed on Mar 23, 2018 by Esperion Therapeutics, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

Section 8/9 declaration window: May 27, 2030

Mark Intelligence

NEXLETOL (Reg. #6064746) is a registered US trademark that has been protecting its owner, Esperion Therapeutics, Inc., since 2018. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Mar 23, 2018

SERIAL

87847415

REG#

6064746

REGISTERED

May 26, 2020

Filing Information

StatusREGISTERED

Filing DateMar 23, 2018

Serial Number87847415

Registration No.6064746

Registration DateMay 26, 2020

Status DateMay 22, 2026

Published for OppositionAug 14, 2018

Filing Basis & Declarations

Standard Characters ClaimedUse Application CurrentlySection 8 AcceptedSection 15 AcknowledgedTrademark

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 006, 018, 044, 046, 051, 052

First use anywhere: Mar 30, 2020

First use in commerce: Mar 30, 2020

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

29 events

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

Sep 21, 2026

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

May 22, 2026

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

May 22, 2026

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

May 18, 2026

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

TEAS SECTION 8 & 15 RECEIVED

Feb 26, 2026

TEAS SECTION 8 & 15 RECEIVED

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

May 26, 2025

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

REGISTERED-PRINCIPAL REGISTER

May 26, 2020

REGISTERED-PRINCIPAL REGISTER

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Apr 21, 2020

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Apr 20, 2020

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Apr 18, 2020

CASE ASSIGNED TO INTENT TO USE PARALEGAL

STATEMENT OF USE PROCESSING COMPLETE

Apr 18, 2020

STATEMENT OF USE PROCESSING COMPLETE

TEAS STATEMENT OF USE RECEIVED

Apr 02, 2020

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

Apr 02, 2020

USE AMENDMENT FILED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Sep 18, 2019

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU EXTENSION 2 GRANTED

Sep 16, 2019

SOU EXTENSION 2 GRANTED

SOU EXTENSION 2 FILED

Sep 16, 2019

SOU EXTENSION 2 FILED

SOU TEAS EXTENSION RECEIVED

Sep 16, 2019

SOU TEAS EXTENSION RECEIVED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Mar 13, 2019

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Mar 11, 2019

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 1 FILED

Mar 11, 2019

SOU EXTENSION 1 FILED

SOU EXTENSION 1 GRANTED

Mar 11, 2019

SOU EXTENSION 1 GRANTED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Oct 09, 2018

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Aug 14, 2018

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Aug 14, 2018

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jul 25, 2018

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

ASSIGNED TO EXAMINER

Jul 09, 2018

ASSIGNED TO EXAMINER

APPROVED FOR PUB - PRINCIPAL REGISTER

Jul 09, 2018

APPROVED FOR PUB - PRINCIPAL REGISTER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Mar 30, 2018

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Mar 27, 2018

NEW APPLICATION ENTERED

Other Marks by Esperion Therapeutics, Inc.

Additional USPTO filings from the same owner.

LIP

LIPID LURKERS

98399636

Esperion Therapeutics, Inc.

REGISTERED

NEX

NEXLIZET

88145092

Esperion Therapeutics, Inc.

REGISTERED

LDL

LDL-C

98539735

Esperion Therapeutics, Inc.

REGISTERED

ESP

ESPERION THERAPEUTICS

75545840

Esperion Therapeutics, Inc.

REGISTERED

Other Marks by Jessica L. Rothstein

Additional USPTO filings handled by the same attorney of record.

DYD

DYDX

98109170

REGISTERED

ART

ART WRKS

99288360

REGISTERED

BOY

BOY SMELLS

88981873

REGISTERED

86975800

REGISTERED

NEXLETOL

Run a conflict check

Other Marks by Esperion Therapeutics, Inc.

Other Marks by Jessica L. Rothstein

Get pre-filing clearance

Search 14M+ trademarks

Resources

Company